GSH

The GSH Group Announces Sale of Foote Hills Property, Achieving Impressive Investor IRR of 15.25%

Retrieved on: 
Tuesday, April 9, 2024
IRR, Sale, Acquisition, GSH, Environment, Commercial property

CLAWSON, Mich., April 9, 2024 /PRNewswire/ -- The GSH Group, one of the nation's fastest-growing multifamily real estate investment companies, is thrilled to announce the successful sale of its Foote Hills property in Grand Rapids, Michigan.

Key Points: 
  • CLAWSON, Mich., April 9, 2024 /PRNewswire/ -- The GSH Group, one of the nation's fastest-growing multifamily real estate investment companies, is thrilled to announce the successful sale of its Foote Hills property in Grand Rapids, Michigan.
  • The sale resulted in an impressive ~18% IRR, while Investors enjoyed a ~10% cash-on-cash yield throughout the holding period of the property.
  • GSH acquired the Foote Hills property in March 2020, recognizing the immense potential in the thriving Grand Rapids submarket.
  • Gideon Pfeffer, CEO & Managing Partner of The GSH Group, expressed his satisfaction with the successful sale, stating, "The sale of Foote Hills marks a significant milestone for The GSH Group and demonstrates our ability to identify and capitalize on investment opportunities in strong markets.

Mitsubishi Corporation Life Sciences Published New Study regarding the Effect of Ingestion of Cysteine Peptide containing Glutathione on Skin Brightness

Retrieved on: 
Tuesday, March 12, 2024
Biotechnology, Other Health, Health, Pharmaceutical, Clinical Trials, Konica Minolta, GSH, Mitsubishi Corporation, Ageing, Tablet, Research, History, Head, Trial of the century, Fermentation, Multimedia

Mitsubishi Corporation Life Sciences Limited (Head Office: Chiyoda-ku, Tokyo Japan; Koji Kishimoto, representative director and president) conducted the clinical study regarding skin brightness in cysteine peptide and published it in Cosmetics 2023, 10, 72.

Key Points: 
  • Mitsubishi Corporation Life Sciences Limited (Head Office: Chiyoda-ku, Tokyo Japan; Koji Kishimoto, representative director and president) conducted the clinical study regarding skin brightness in cysteine peptide and published it in Cosmetics 2023, 10, 72.
  • In this study, Mitsubishi Corporation Life Sciences defined glutathione (GSH), cysteinylglycine (Cys-Gly), and glutamylcysteine (-Glu-Cys) as cysteine peptide and performed a randomized, double-blind, placebo-controlled study to investigate the effects of orally administered cysteine peptide on human skin brightness.
  • Eligible participants were randomly allocated into three groups (cysteine peptide 45 mg: n = 16, 90 mg: n = 15, and placebo: n = 16).
  • Mitsubishi Corporation Life Sciences has the affiliate of KOHJIN Life Sciences which is the manufacturer of Glutathione located in Japan.

DiamondHead Holdings Corp. Announces PIPE Investment

Retrieved on: 
Wednesday, March 22, 2023
Residential Building & Real Estate, Construction & Property, Professional Services, Finance, GSH, The Notes, Note, PIPE, Sub, Business analyst, PAETEC Holding Corp., Diamond, Issuer, Combination, Security (finance), Share (finance)

The aggregate gross amount of the PIPE Investment is $75,000,000.

Key Points: 
  • The aggregate gross amount of the PIPE Investment is $75,000,000.
  • The closing of the Note Purchase Agreement is contingent upon the substantially concurrent consummation of the Business Combination and other customary closing conditions.
  • The purpose of the PIPE Investment is to raise additional capital for use by the Issuer following the closing of the Business Combination.
  • In addition, one of the Investors will have the right to designate a member of the board of directors of DHHC following the closing of the PIPE Investment.

Grindrod Shipping Holdings Ltd. Announces Unaudited Financial Results for the Three Months & Year Ended December 31, 2022

Retrieved on: 
Wednesday, February 15, 2023
GDP, Three Months, United States Shipping Board, Date, Ship, Offer, Compensation, EBITDA, GAAP, Audit, Offer and acceptance, Sale, Interim, FSP, JSE, ARC, Frisbee, TIA, Vulnerability and Risk Committee, GSH, Handymax, Growth, CNC, Committee, Lunar New Year, TMI, TCE, Airline, Cryptocurrency, Bank, Holding company, Semiconductor, Management

Vessel revenue was $81.2 million for the three months ended December 31, 2022 and $142.3 million for the three months ended December 31, 2021.

Key Points: 
  • Vessel revenue was $81.2 million for the three months ended December 31, 2022 and $142.3 million for the three months ended December 31, 2021.
  • Interest income was $1.4 million for the three months ended December 31, 2022 and $0.1 million for the three months ended December 31, 2021.
  • Interest expense was $5.3 million for the three months ended December 31, 2022 and $2.8 million for the three months ended December 31, 2021.
  • Unaudited Results for the Year Ended December 31, 2022 and 2021
    Revenue was $460.5 million for the year ended December 31, 2022 and $455.8 million for the year ended December 31, 2021.

The inaugural Global Stage Hollywood Film Festival Launches with Film Screening Poupelle of Chimney Town, an award-winning animated feature from Japan

Retrieved on: 
Friday, October 14, 2022
Aurora, 74th Academy Awards, Grauman's Chinese Theatre, Non-fungible token, GSH, Woman, Academy Award for Best International Feature Film, Union Bank, Poupelle of Chimney Town, Globe de Cristal Awards, CV19, Animation, Industry, Sapporo Breweries, CEO, Consulate-General of Japan, Detroit, Academy Awards, Sonic Team, Taipei Film Awards, Golden Horse Film Festival and Awards, Consulate, ANNIE, Film, Entertainment, Global, Japan Airlines, Fantasia

This year's festival is being produced by Douglas Montgomery, founder and CEO of media consulting company, Global Connects Media.

Key Points: 
  • This year's festival is being produced by Douglas Montgomery, founder and CEO of media consulting company, Global Connects Media.
  • "The changes in the global entertainment industry have been accelerated greatly by the effects of CV19 and the work from-home-culture.
  • Global Stage Hollywood was established to create a platform for diverse creators from all over the world.
  • With a mixture of in-person events including our marquee festival at the world-famous Chinese Theatre in Hollywood, small boutiquescreenings, business panels, and even digital roundtables, Global Stage Hollywood aims to serve the under-served.

DiamondHead Holdings Corp. Announces Filing a Registration Statement on Form S-4 in Connection with a Proposed Business Combination with Great Southern Homes, Inc.

Retrieved on: 
Thursday, October 13, 2022
Finance, Professional Services, Residential Building & Real Estate, Asset Management, Construction & Property, U.S. Securities and Exchange Commission, Ludlow Street (Manhattan), XV, 100,000, Communication, Risk, Registration statement, SEC, GSH, Southeastern United States, Growth, Xi, Person, NASDAQ, Register, Securities Act of 1933, Company, Acquisition, Reading, Industry, Ix, Form, Vii, Proxy, Prospectus, Failure, Terminology, Security (finance), Audit, Bank

The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previously announced business combination between DHHC and GSH.

Key Points: 
  • The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previously announced business combination between DHHC and GSH.
  • Although the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about DHHC and GSH, as well as the proposed business combination.
  • GSH is one of the largest and most established homebuilders in the Southeast, having closed at least 10,000 homes over the last two decades.
  • The Company currently has a presence in South Carolina and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first move-up segments.

Metabolism-Dependent Cytotoxicity Assay (MDCA) for the Evaluation of the DILI Potential of Drug Candidates, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, October 4, 2022
GSH, Evaluation, Toxicity, Food, Doctor of Philosophy, Hepatotoxicity, Drug development, Pharmacology, Industry, Immortalised cell line, Glutathione, Hepatocyte, MDC, HEK293, Enzyme, Mitochondrial outer membrane permeabilization, Disulfiram-like drug, Toxicology, MDCA, Pharmaceutical industry

TORONTO , Oct. 4, 2022  /PRNewswire-PRWeb/ -- The metabolic activation and detoxification pathways of drug candidates is an important aspect of drug development. This information can be applied towards structural design to minimize toxicological liability of drug candidates, selection of animal species for preclinical evaluation of human toxicity, identification of at-risk populations based on metabolic activation and detoxification capacity and identification of environmental factors that may exacerbate drug toxicity via their induction of metabolic activating pathways and inhibition of detoxification pathways. An in vitro cytotoxicity assay can help enable this process.

Key Points: 
  • Attendees will learn the basis of developing the metabolism-dependent cytotoxicity assay (MDCA) and the utility of the MDCA.
  • The featured speaker will discuss plans to develop the MDC Index for comparative analysis to known drug-induced liver injury (DILI) drugs.
  • TORONTO, Oct. 4, 2022 /PRNewswire-PRWeb/ -- The metabolic activation and detoxification pathways of drug candidates is an important aspect of drug development.
  • For more information, or to register for this event, visit Metabolism-Dependent Cytotoxicity Assay (MDCA) for the Evaluation of the DILI Potential of Drug Candidates .

Great Southern Homes, Inc. and DiamondHead Holdings Corp. Announce Investor Call to Discuss Their Upcoming Business Combination

Retrieved on: 
Thursday, September 29, 2022
Residential Building & Real Estate, Construction & Property, REIT, Ix, XV, Whitehall, Goldman, 100,000, GSH, Risk, Interest, ID, Company, Acquisition, Growth, Industry, Securities Act of 1933, Person, Investment, Xi, Terminology, NorthStar, Annual report, Reading, NASDAQ, Form, Diamond, Prospectus, Proxy, SEC, Vii, Webcast, Communication, Failure, Solicitation, Security (finance), Risk management, Ownership

Great Southern Homes, Inc. (GSH or the Company) and DiamondHead Holdings Corp. (NASDAQ: DHHC) (DiamondHead or DHHC) will hold an investor call on Monday, October 3, 2022 at 1:00 PM ET to discuss their upcoming business combination.

Key Points: 
  • Great Southern Homes, Inc. (GSH or the Company) and DiamondHead Holdings Corp. (NASDAQ: DHHC) (DiamondHead or DHHC) will hold an investor call on Monday, October 3, 2022 at 1:00 PM ET to discuss their upcoming business combination.
  • The event will feature a presentation by key members of both companies accompanied by a slide deck, followed by a question-and-answer period.
  • Interested parties can access the call by dialing (669) 900-9128 with a meeting ID of 838 2395 9794.
  • On September 12, 2022, GSH and DiamondHead announced that they entered into a definitive business combination agreement.

Great Southern Homes, Inc., a Leading Private Homebuilder in the Southeast, to Become a Public Company Through a Business Combination with DiamondHead Holdings Corp. Under the Name United Homes Group, Inc. (UHG)

Retrieved on: 
Monday, September 12, 2022
Interior Design, Architecture, Other Construction & Property, Residential Building & Real Estate, Construction & Property, Building Systems, Landscape, Goldman, 100,000, CIO, EBITDA, Future, Oliver Cromwell, UHG, Industry, DHP, Investment, U.S. Securities and Exchange Commission, Xi, Reading, NASDAQ, Sponsor, Communication, Zonda, Whitehall, GSH, Company, Acquisition, Growth, Person, M&A, NorthStar, Annual report, Prospectus, SEC, Failure, XV, Vii, View, Ix, Nasdaq, Risk, Population, CEO, Business architecture, Board, Freddie Mac, Security (finance), Proxy, Housing, LLC, Sullivan & Cromwell, Securities Act of 1933, Terminology, Form, Diamond, Real estate, Financial services, Film, Oil, Bank, Cryptocurrency, Risk management, Ownership

The Company builds homes in South Carolina and Georgia, focusing on the entry level and first time move up home buyer segments.

Key Points: 
  • The Company builds homes in South Carolina and Georgia, focusing on the entry level and first time move up home buyer segments.
  • A 2021 FHLMC (Freddie Mac) study estimated that the U.S. is 4.4 million homes short of demand (based on household formations).
  • Established Track Record: Founded by Michael Nieri and based in Columbia, South Carolina, GSH is one of the largest private homebuilders in the Southeast.
  • Michael Nieri, Founder and CEO of Great Southern Homes, said, For over 20 years I have worked to build GSH into the leading Southeast homebuilder it is today.

ProthioneTM Capsules Reduced Time to COVID-19 Clinical Resolution and Decreased Viral Load in Phase II Clinical Trial

Retrieved on: 
Wednesday, June 15, 2022
Infectious Diseases, Pharmaceutical, Health, Clinical Trials, Time, College, Viral load, Drug development, COVID-19, Drug, Science, Ministry, GSH, Efficacy, Capsule, LLC, Research, Oxidative stress, Glutathione, N95, Disease, Severe acute respiratory syndrome coronavirus 2, University, Ministry of Health (Saudi Arabia), Biomarker, Phase, Safety, Sale, RT, HIV, Organic acid, Patient, Hospital, N83, Moderate, Pharmaceutical industry, Vaccine, MD, Health, Pharmacist

Prothione LLC, an innovative, U.S. based pharmaceutical company announced today positive results from a Phase II trial of Prothione capsules for the treatment of mild to moderate COVID-19.

Key Points: 
  • Prothione LLC, an innovative, U.S. based pharmaceutical company announced today positive results from a Phase II trial of Prothione capsules for the treatment of mild to moderate COVID-19.
  • The capsules contain three amino acids known to increase intracellular glutathione, reduce oxidative stress, and inhibit inflammatory reactions in patients with COVID-19.
  • HIV-positive patients with mild to moderate symptoms from COVID-19 on Prothione capsules experienced dramatic drops in HIV viral load.
  • Prothione LLC presented results of the Phase II clinical trial to a wide range of researchers, healthcare workers, government officials and non-government organizations in Kigali on June 3.